Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSDL2 antisense RNA 1 (HSDL2-AS1)
- Target
- HSDL2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
HSDL2 antisense RNA 1 (HSDL2-AS1) is a long non-coding RNA (lncRNA) located on chromosome 9, also known as bA32M23.3 or C9orf147[8]. It is classified as an RNA gene of the lncRNA class. HSDL2-AS1 does not encode a protein and is distinct from the protein-coding gene HSDL2. Current studies have found it differentially expressed in malignant pheochromocytoma and gastric cancer, suggesting it may serve as a biomarker for these diseases[1][2][6]. However, its precise biological function, molecular interactions, and therapeutic targetability remain unknown, and there are no known drug interactions or established roles as a direct pharmacological target[2][6].
- Other names
- bA32M23.3C9orf147BA32M23.3
02
Biological functions
Unknown; lncRNAs can regulate gene expressionRNA interaction networksmay have roles in carcinogenesis
03
Disease associations
Cancer (evidence for differential expression in malignant pheochromocytoma and gastric cancer; biomarker roles studied but function not well established)
04
Biomarkers
Potential biomarker for malignant pheochromocytoma and differential expression in certain cancers
Beyond the preview
Go deeper on HSDL2 antisense RNA 1 (HSDL2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HSDL2 antisense RNA 1 (HSDL2-AS1).